North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024

List of Tables

The North America Cat Vaccine Market would witness market growth of 8.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).

The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.

Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.

In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Zoetis, Inc.
Elanco Animal Health, Inc.
Merck & Co., Inc.
Boehringer Ingelheim International GmbH
Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
Virbac
Heska Corporation (Antech Diagnostics, Inc)
Ceva Sante Animale
Bioveta, a.s.

North America Cat Vaccine Market Report Segmentation

By Component

Combined Vaccines
Mono Vaccines

By Route of Administration

Injectables
Intranasal
Oral

By Duration of Immunity

1 Year
3 Year
Others

By Disease Type

Feline Respiratory Diseases
Feline Rabies
Feline Panleukopenia (Feline Distemper)
Feline Leukemia
Others

By Type

Modified/Attenuated Live
Inactivated (Killed)
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Cat Vaccine Market, by Component
- 1.4.2 North America Cat Vaccine Market, by Route of Administration
- 1.4.3 North America Cat Vaccine Market, by Duration of Immunity
- 1.4.4 North America Cat Vaccine Market, by Disease Type
- 1.4.5 North America Cat Vaccine Market, by Type
- 1.4.6 North America Cat Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Cat Vaccine Market

Chapter 5. North America Cat Vaccine Market by Component

5.1 North America Combined Vaccines Market by Region
5.2 North America Mono Vaccines Market by Region

Chapter 6. North America Cat Vaccine Market by Route of Administration

6.1 North America Injectables Market by Country
6.2 North America Intranasal Market by Country
6.3 North America Oral Market by Country

Chapter 7. North America Cat Vaccine Market by Duration of Immunity

7.1 North America 1 Year Market by Country
7.2 North America 3 Year Market by Country
7.3 North America Others Market by Country

Chapter 8. North America Cat Vaccine Market by Disease Type

8.1 North America Feline Respiratory Diseases Market by Country
8.2 North America Feline Rabies Market by Country
8.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
8.4 North America Feline Leukemia Market by Country
8.5 North America Others Market by Country

Chapter 9. North America Cat Vaccine Market by Type

9.1 North America Modified/Attenuated Live Market by Country
9.2 North America Inactivated (Killed) Market by Country
9.3 North America Others Market by Country

Chapter 10. North America Cat Vaccine Market by Country

10.1 US Cat Vaccine Market
- 10.1.1 US Cat Vaccine Market by Component
- 10.1.2 US Cat Vaccine Market by Route of Administration
- 10.1.3 US Cat Vaccine Market by Duration of Immunity
- 10.1.4 US Cat Vaccine Market by Disease Type
- 10.1.5 US Cat Vaccine Market by Type
10.2 Canada Cat Vaccine Market
- 10.2.1 Canada Cat Vaccine Market by Component
- 10.2.2 Canada Cat Vaccine Market by Route of Administration
- 10.2.3 Canada Cat Vaccine Market by Duration of Immunity
- 10.2.4 Canada Cat Vaccine Market by Disease Type
- 10.2.5 Canada Cat Vaccine Market by Type
10.3 Mexico Cat Vaccine Market
- 10.3.1 Mexico Cat Vaccine Market by Component
- 10.3.2 Mexico Cat Vaccine Market by Route of Administration
- 10.3.3 Mexico Cat Vaccine Market by Duration of Immunity
- 10.3.4 Mexico Cat Vaccine Market by Disease Type
- 10.3.5 Mexico Cat Vaccine Market by Type
10.4 Rest of North America Cat Vaccine Market
- 10.4.1 Rest of North America Cat Vaccine Market by Component
- 10.4.2 Rest of North America Cat Vaccine Market by Route of Administration
- 10.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
- 10.4.4 Rest of North America Cat Vaccine Market by Disease Type
- 10.4.5 Rest of North America Cat Vaccine Market by Type

Chapter 11. Company Profiles

11.1 Zoetis, Inc.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
  - 11.1.5.1 Partnerships, Collaborations, and Agreements:
  - 11.1.5.2 Product Launches and Product Expansions:
  - 11.1.5.3 Acquisition and Mergers:
- 11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expenses
- 11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Regional & Segmental Analysis
- 11.4.4 Research & Development Expenses
- 11.4.5 Recent strategies and developments:
  - 11.4.5.1 Trials and Approvals:
- 11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- 11.5.1 Company Overview
- 11.5.2 SWOT Analysis
11.6 Virbac
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Recent strategies and developments:
  - 11.6.4.1 Acquisition and Mergers:
- 11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
- 11.7.1 Company Overview
- 11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
- 11.8.1 Company Overview
- 11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
- 11.9.1 Company Overview

LIST OF TABLES

TABLE 1 North America Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 2 North America Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 3 North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 4 North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 5 North America Combined Vaccines Market by Region, 2020 - 2023, USD Million
TABLE 6 North America Combined Vaccines Market by Region, 2024 - 2031, USD Million
TABLE 7 North America Mono Vaccines Market by Region, 2020 - 2023, USD Million
TABLE 8 North America Mono Vaccines Market by Region, 2024 - 2031, USD Million
TABLE 9 North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 10 North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 11 North America Injectables Market by Country, 2020 - 2023, USD Million
TABLE 12 North America Injectables Market by Country, 2024 - 2031, USD Million
TABLE 13 North America Intranasal Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Intranasal Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Oral Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Oral Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 18 North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 19 North America 1 Year Market by Country, 2020 - 2023, USD Million
TABLE 20 North America 1 Year Market by Country, 2024 - 2031, USD Million
TABLE 21 North America 3 Year Market by Country, 2020 - 2023, USD Million
TABLE 22 North America 3 Year Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 26 North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 27 North America Feline Respiratory Diseases Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Feline Respiratory Diseases Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Feline Rabies Market by Country, 2020 - 2023, USD Million
TABLE 30 North America Feline Rabies Market by Country, 2024 - 2031, USD Million
TABLE 31 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Feline Panleukopenia (Feline Distemper) Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Feline Leukemia Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Feline Leukemia Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 38 North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 39 North America Modified/Attenuated Live Market by Country, 2020 - 2023, USD Million
TABLE 40 North America Modified/Attenuated Live Market by Country, 2024 - 2031, USD Million
TABLE 41 North America Inactivated (Killed) Market by Country, 2020 - 2023, USD Million
TABLE 42 North America Inactivated (Killed) Market by Country, 2024 - 2031, USD Million
TABLE 43 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 44 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 45 North America Cat Vaccine Market by Country, 2020 - 2023, USD Million
TABLE 46 North America Cat Vaccine Market by Country, 2024 - 2031, USD Million
TABLE 47 US Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 48 US Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 49 US Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 50 US Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 51 US Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 52 US Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 53 US Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 54 US Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 55 US Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 56 US Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 57 US Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 58 US Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 59 Canada Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 60 Canada Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 61 Canada Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 62 Canada Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 63 Canada Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 64 Canada Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 65 Canada Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 66 Canada Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 67 Canada Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 68 Canada Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 69 Canada Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 70 Canada Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 71 Mexico Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 72 Mexico Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 73 Mexico Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 74 Mexico Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 75 Mexico Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 76 Mexico Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 77 Mexico Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 78 Mexico Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 79 Mexico Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 80 Mexico Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 81 Mexico Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 82 Mexico Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of North America Cat Vaccine Market, 2020 - 2023, USD Million
TABLE 84 Rest of North America Cat Vaccine Market, 2024 - 2031, USD Million
TABLE 85 Rest of North America Cat Vaccine Market by Component, 2020 - 2023, USD Million
TABLE 86 Rest of North America Cat Vaccine Market by Component, 2024 - 2031, USD Million
TABLE 87 Rest of North America Cat Vaccine Market by Route of Administration, 2020 - 2023, USD Million
TABLE 88 Rest of North America Cat Vaccine Market by Route of Administration, 2024 - 2031, USD Million
TABLE 89 Rest of North America Cat Vaccine Market by Duration of Immunity, 2020 - 2023, USD Million
TABLE 90 Rest of North America Cat Vaccine Market by Duration of Immunity, 2024 - 2031, USD Million
TABLE 91 Rest of North America Cat Vaccine Market by Disease Type, 2020 - 2023, USD Million
TABLE 92 Rest of North America Cat Vaccine Market by Disease Type, 2024 - 2031, USD Million
TABLE 93 Rest of North America Cat Vaccine Market by Type, 2020 - 2023, USD Million
TABLE 94 Rest of North America Cat Vaccine Market by Type, 2024 - 2031, USD Million
TABLE 95 Key Information - Zoetis, Inc.
TABLE 96 Key information - Elanco Animal Health, Inc.
TABLE 97 Key Information - Merck & Co., Inc.
TABLE 98 Key Information - Boehringer Ingelheim International GmbH
TABLE 99 Key Information - Covetrus, Inc.
TABLE 100 Key Information - Virbac
TABLE 101 Key Information - Heska Corporation
TABLE 102 Key Information - Ceva SantE Animale
TABLE 103 Key Information - Bioveta, a.s.

North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents